Tandem Diabetes Care (TNDM) Net Margin (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Net Margin came in at 8.33% in Q2 2026, up 1344.0% on a YoY basis from 0.58% in Q2 2025, and down 0.89% quarter-over-quarter from 8.26% in Q1 2026.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Net Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Net Margin for 14 consecutive years, with 8.33% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 1344.0% year-over-year to 8.33%; the trailing twelve-month figure through Jun 2026 stood at 6.08% (up 1443.0% YoY), and the FY2025 full-year result was 20.17%, down 996.0% from the prior year.
- Net Margin retreated to 8.33% in Q2 2026 per TNDM's latest filing, from 8.26% in the prior quarter.
- Across five years, Net Margin topped out at 0.27% in Q4 2024 and bottomed at 73.15% in Q1 2023.
- Historically, Net Margin has averaged 17.76% across 5 years, with a median of 11.71% in 2024.
- The sharpest annual moves came in 2023 and 2024: Net Margin plunged 6478 bps in 2023, then soared 5086 bps in 2024.
- Over 5 years, Net Margin stood at 7.19% in 2022, then plunged by 112 bps to 15.23% in 2023, then surged by 102 bps to 0.27% in 2024, then sank by 168 bps to 0.19% in 2025, then plunged by 4356 bps to 8.33% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 8.33%, 8.26%, and 0.19% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 13.47% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 804.14 Mn | 144.78 Mn | -8.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.33% |
| Mar 31, 2026 | -8.26% |
| Dec 31, 2025 | -0.19% |
| Sep 30, 2025 | -8.48% |
| Jun 30, 2025 | -21.77% |
| Mar 31, 2025 | -55.71% |
| Dec 31, 2024 | 0.27% |
| Sep 30, 2024 | -9.53% |
| Jun 30, 2024 | -13.90% |
| Mar 31, 2024 | -22.29% |
| Dec 31, 2023 | -15.23% |
| Sep 30, 2023 | -17.76% |
| Jun 30, 2023 | -18.26% |
| Mar 31, 2023 | -73.15% |
| Dec 31, 2022 | -7.19% |
| Sep 30, 2022 | -23.94% |
| Jun 30, 2022 | -7.54% |
| Mar 31, 2022 | -8.37% |
| Dec 31, 2021 | 5.13% |
| Sep 30, 2021 | 3.20% |